| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/25/2010 | US20100074947 Pharmaceutical Formulations |
| 03/25/2010 | US20100074946 Process for preparing purified nucleic acid and the use thereof |
| 03/25/2010 | US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
| 03/25/2010 | US20100074944 Transdermal Tobacco Alkaloid Reservoir Patch |
| 03/25/2010 | US20100074943 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 03/25/2010 | US20100074942 Device and method for intraocular drug delivery |
| 03/25/2010 | US20100074941 Absorbable, permeability-modulated barrier composites and applications thereof |
| 03/25/2010 | US20100074939 Harmine compounds for promoting bone growth |
| 03/25/2010 | US20100074938 Immobilised biological entities |
| 03/25/2010 | US20100074935 Recombinant lubricin molecules and uses thereof |
| 03/25/2010 | US20100074934 Medical implants with a combination of compounds |
| 03/25/2010 | US20100074933 Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides |
| 03/25/2010 | US20100074931 Use of a highly emulsified silicone oil (hes) for the production of a medicament |
| 03/25/2010 | US20100074930 Method of making polymer hollow particles with controllable holes in their surfaces |
| 03/25/2010 | US20100074927 Delivery of therapeutic compounds via microparticles or microbubbles |
| 03/25/2010 | US20100074926 Modules, new assemblage kits and new assembles for the controlled release of substances |
| 03/25/2010 | US20100074914 DNA vaccine comprising CTGF-encoding DNA construct and applications thereof |
| 03/25/2010 | US20100074913 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
| 03/25/2010 | US20100074891 Sclerostin and the inhibition of Wnt signaling and bone formation |
| 03/25/2010 | US20100074849 Organic acid free effervescent formulation |
| 03/25/2010 | US20100072222 Apparatus and methods for dispensing pet care substances |
| 03/25/2010 | DE102008048729A1 Multipartikuläre Tabletten und Verfahren zur deren Herstellung Multiparticulate tablets and processes for their preparation |
| 03/25/2010 | CA2738707A1 Method for the preparation of a controlled release system |
| 03/25/2010 | CA2737671A1 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| 03/25/2010 | CA2737543A1 Composite organic compound powder for medical use and production method and suspension of the same |
| 03/25/2010 | CA2737528A1 Granulates, process for preparing them and pharmaceutical products containing them |
| 03/25/2010 | CA2737484A1 Microencapsulation process with solvent and salt |
| 03/25/2010 | CA2737475A1 Tetracycline stabilizing formulations |
| 03/25/2010 | CA2737463A1 Freeze-dried powder preparation of tetrodotoxin and the producing method thereof |
| 03/25/2010 | CA2737421A1 A stimulatable asymmetrical polymersome |
| 03/25/2010 | CA2737380A1 Tabletting excipient based on lactose and cellulose |
| 03/25/2010 | CA2737257A1 Pharmaceutical dosage forms comprising poly(.epsilon.-caprolactone) |
| 03/25/2010 | CA2737135A1 Methods and kits for treating cluster headache disorders |
| 03/25/2010 | CA2736864A1 Stable liquid antibody formulation |
| 03/25/2010 | CA2736531A1 Process for preparing snuff composition |
| 03/25/2010 | CA2736257A1 Galenical formulations of organic compounds |
| 03/25/2010 | CA2736198A1 Novel antibody formulation |
| 03/25/2010 | CA2736106A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same |
| 03/25/2010 | CA2736020A1 An inserter |
| 03/25/2010 | CA2735952A1 An inserter |
| 03/25/2010 | CA2735933A1 An inserter |
| 03/25/2010 | CA2734402A1 Nicotine-containing granulate |
| 03/25/2010 | CA2732893A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers. |
| 03/25/2010 | CA2725381A1 Nanoemulsion adjuvants |
| 03/25/2010 | CA2702604A1 Transdermal drug delivery using an osmolyte and vasoactive agent |
| 03/24/2010 | EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells |
| 03/24/2010 | EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof |
| 03/24/2010 | EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 03/24/2010 | EP2165706A1 Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers. |
| 03/24/2010 | EP2165703A2 Direct compression formulation and process |
| 03/24/2010 | EP2165702A1 Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation |
| 03/24/2010 | EP2165701A1 Antimicrobial and antiviral compound |
| 03/24/2010 | EP2165694A1 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 03/24/2010 | EP2164631A1 Modifying drug release in suspensions of ionic resin systems |
| 03/24/2010 | EP2164622A1 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles |
| 03/24/2010 | EP2164533A1 Strontium fortified calcium nano- and microparticle compositions and methods of making and using thereof |
| 03/24/2010 | EP2164518A1 Formulations for the oral administration of therapeutic agents and related methods |
| 03/24/2010 | EP2164497A1 A drug delivery system for the prevention of cerebral vasospasm |
| 03/24/2010 | EP2164476A1 Topical composition for treating pain |
| 03/24/2010 | EP2164475A2 Therapeutic stable nanoparticles |
| 03/24/2010 | EP2164474A2 Water dispersible polymer compositions |
| 03/24/2010 | EP2164473A1 An extended-release composition comprising a somatostatin derivative in microparticles |
| 03/24/2010 | EP2164472A1 Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
| 03/24/2010 | EP2164470A1 Pharmaceutical composition comprising desloratadine |
| 03/24/2010 | EP2164469A2 Stable formulation of amorphous perindopril salts, a process for the preparation thereof on industrial scale and use thereof in the treatment of hypertension |
| 03/24/2010 | EP2164468A1 Method for the production of a form of administration of a medicament |
| 03/24/2010 | EP2164467A2 Slow release pharmaceutical composition made of microparticles |
| 03/24/2010 | EP2164466A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier |
| 03/24/2010 | EP2164465A1 Self-emulsifying formulation of tipranavir for oral administration |
| 03/24/2010 | EP2164464A2 Multi-dose concentrate esmolol with benzyl alcohol |
| 03/24/2010 | EP2164463A1 Concentrate esmolol |
| 03/24/2010 | EP2164462A2 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 03/24/2010 | EP2164461A1 Pharmaceutical formulation for the production of chewable tablets and lozenges |
| 03/24/2010 | EP2164460A1 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 03/24/2010 | EP2164459A1 Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | EP2164458A1 Stable non-aqueous pharmaceutical compositions |
| 03/24/2010 | EP2164384A2 Hydrogel implant for sensing metabolites in body tissue |
| 03/24/2010 | EP2164351A1 Disperse base material |
| 03/24/2010 | EP2164343A1 In situ, liquid-activated film coated tablets and a process for making the same |
| 03/24/2010 | EP1877059B1 Micronized tanaproget and compostions containing same |
| 03/24/2010 | EP1711164B1 Method of treating acute rhinosinusitis |
| 03/24/2010 | EP1620060B1 Methods and devices for the sustained release of multiple drugs |
| 03/24/2010 | EP1581583B1 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles |
| 03/24/2010 | EP1112005B2 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 03/24/2010 | CN201426858Y Clopidogrel hydrogen shlfate and aspirin double-layer tablet |
| 03/24/2010 | CN201426857Y Amoxicillin long-acting granular pill |
| 03/24/2010 | CN201426856Y Tilmicosin enteric coated granule |
| 03/24/2010 | CN201426855Y Florfenicol enteric coated granule |
| 03/24/2010 | CN101679390A Ground crystal of olmesartan medoxomil |
| 03/24/2010 | CN101679328A Prophylactic or therapeutic agent for age-related macular degeneration |
| 03/24/2010 | CN101678306A Large coacervated capsules |
| 03/24/2010 | CN101678115A Pharmaceutical composition comprising porous dry matrix |
| 03/24/2010 | CN101678114A Solid dosage forms |
| 03/24/2010 | CN101678113A Low-molecule drug-containing nanoparticle having sustained release negatively charged group |
| 03/24/2010 | CN101678112A Methods and compositions for the delivery of a therapeutic agent |
| 03/24/2010 | CN101678111A Colored esmolol concentrate |
| 03/24/2010 | CN101678110A Solid dialysis preparation |
| 03/24/2010 | CN101678094A formulation of meningitis vaccines |
| 03/24/2010 | CN101678086A 固体纤维蛋白原制剂 The solid fibrinogen preparation |
| 03/24/2010 | CN101678083A pharmaceutical formulations of ghrh molecules |